Discover
SNOA
Sonoma Pharmaceuticals, Inc.
1.34
1 x 1.22
1 x 1.38
bid
ask
-
0.03
2.19%
100 @ 04:00 PM
1.37 +0.03 (2.06%)
| Ytd | -63.19% | |
| 1y | -56.07% |
1.30
day range
1.37
0.85
52 week range
6.92
| Open | 1.36 | Prev Close | 1.37 | Low | 1.30 | High | 1.37 | Mkt Cap | 2.26M |
| Vol | 154.87K | Avg Vol | 170.04K | EPS | -1.18 | P/E | -1.14 | Forward P/E | -1.49 |
| Beta | 1.38 | Short Ratio | 0.22 | Inst. Own | 2.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.19 | 200-d Avg | 2.36 | 1yr Est | 19.50 |
| Income Statement | |||
| Total Revenue | 6.41M | ||
| Revenues (USD) | 6.41M | ||
| Cost of Revenue | 3.83M | ||
| Gross Profit | 2.58M | ||
| Operating Expenses | 2.62M | ||
| Research and Development Expense | 597.00K | ||
| Selling, General and Administrative Expense | 2.02M | ||
| Operating Income | -40.00K | ||
| Net Income | -330.00K | ||
| Net Income Common Stock | -330.00K | ||
| Net Income Common Stock (USD) | -330.00K | ||
| Consolidated Income | -330.00K | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -330.00K | ||
| Earning Before Interest & Taxes (USD) | -330.00K | ||
| Weighted Average Shares | 3.85M | ||
| Weighted Average Shares Diluted | 3.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.34M | ||
| Cash and Equivalents (USD) | 5.34M | ||
| Trade and Non-Trade Receivables | 3.18M | ||
| Current Assets | 16.27M | ||
| Property, Plant & Equipment Net | 868.00K | ||
| Total Assets | 18.11M | ||
| Debt Current | 300.00K | ||
| Total Debt | 739.00K | ||
| Current Liabilities | 5.45M | ||
| Debt Non-Current | 439.00K | ||
| Total Liabilities | 11.51M | ||
| Accumulated Retained Earnings (Deficit) | -201.31M | ||
| Accumulated Other Comprehensive Income | -3.01M | ||
| Shareholders Equity | 6.59M | ||
| Shareholders Equity (USD) | 6.59M | ||
| Assets Non-Current | 1.84M | ||
| Total Debt (USD) | 739.00K | ||
| Deferred Revenue | 282.00K | ||
| Inventory | 3.79M | ||
| Liabilities Non-Current | 6.07M | ||
| Trade and Non-Trade Payables | 2.19M | ||
| Tax Assets | 905.00K | ||
| Tax Liabilities | 5.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 32.00K | ||
| Net Cash Flow from Financing | 3.45M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.94M | ||
| Capital Expenditure | -2.00K | ||
| Issuance (Purchase) of Equity Shares | 3.54M | ||
| Issuance (Repayment) of Debt Securities | -82.00K | ||
| Net Cash Flow from Investing | -2.00K | ||
| Net Cash Flow from Operations | -649.00K | ||
| Effect of Exchange Rate Changes on Cash | 136.00K | ||
| Share Based Compensation | 58.00K | ||